neuroscience

First Opinion William G. Woods

As a pediatric cancer researcher, I admired the FDA. Then I got ALS

In the Lab Akila Muthukumar

From the Navy to a neuroscience lab: how a daughter’s diagnosis spurred her mother’s career shift

In the Lab Jonathan Wosen

How does the brain decide what memories are good and bad? A new mouse study offers clues

In the Lab Kasra Zarei

Three burning questions about the first brain reference charts

Biotech Allison DeAngelis

Startups are turning to a century-old technology to fuel a resurgence in neuro drug development

In the Lab Jonathan Wosen

Swapping out the brain’s cleanup crew treats neurological disease in mice, study shows

First Opinion David Beier, Lucy Nalbach Tournas and Gary Marchant

Applied neuroscience needs a task force to craft effective governance

First Opinion Rev. Alvin C. Hathaway Sr.

A preacher’s new calling: Connecting neuroscience researchers as a way to advance social justice

In the Lab Jonathan Wosen

Researchers use ultrasound to precisely and safely activate brain cells in mice

In the Lab Isabella Cueto

Walking again after paralysis: Early study suggests stimulation could jolt spinal cord back to life

Special Report Isabella Cueto

Jolting the brain’s circuits with electricity is moving from radical to almost mainstream therapy. Some crucial hurdles remain

In the Lab Angus Chen

Mutations tied to blood cancers and other diseases may surprisingly protect against Alzheimer’s

In the Lab Megan Molteni

In the blood of marathoning mice, scientists find clues to how exercise benefits the brain

In the Lab Megan Molteni

Using optogenetics, scientists pinpoint the location and timing of memory formation in mice

First Opinion Kao Lee Yang

I’m almost always the only Hmong American scientist in the room. Yet I was told I come from a group overrepresented in STEM

Biotech Kate Sheridan

Startup Spotlight: Vigil Neuroscience hopes to eventually target the rare disease ALSP 

In the Lab Claudia López Lloreda

Researchers use machine learning to translate brain signals from a paralyzed patient into text

Exclusive Olivia Goldhill

Athira Pharma CEO placed on leave amid allegations of altered images in her research papers

First Opinion Dana P. Goldman and Darius Lakdawalla

FDA’s approval of aducanumab paves the way for ‘more momentous’ Alzheimer’s breakthroughs

Biotech Adam Feuerstein

STAT+ Conversations: A conversation on the latest in neuroscience and CNS drug development

First Opinion Anna Wexler

A skeptic’s take on Neuralink and other consumer neurotech

In the Lab Usha Lee McFarling

New monkey model of Alzheimer’s disease may accelerate search for human treatments

In the Lab Usha Lee McFarling

‘It looks like a spaghetti bowl’: Scientists reveal a precise structure in a fabled worm’s tangled brain

Biotech Matthew Herper

Experts encouraged by Denali’s early results in study of Hunter syndrome drug

In the Lab Eric Boodman

Genetic reprogramming rejuvenates nerve cells and restores vision in mice